Investors & Media Company Overview UNITY Biotechnology is developing therapeutics to extend human healthspan by slowing, halting or reversing diseases of aging. UNITY's initial focus is on creating senolytic medicines to selectively eliminate senescent cells and thereby treat age-related diseases, such as osteoarthritis, eye diseases and pulmonary diseases. Stock Information Data Provided by Refinitiv. Minimum 15 minutes delayed. Latest Presentation Download News Releases August 4, 2020 UNITY Biotechnology Announces $80M Debt Financing From Hercules Capital July 31, 2020 UNITY Biotechnology, Inc. Reports Second Quarter 2020 Financial Results and Clinical Program Updates
July 31, 2020 UNITY Biotechnology, Inc. Reports Second Quarter 2020 Financial Results and Clinical Program Updates
